Mechanisms of p-Methoxycinnamic acid-induced increase in insulin secretion

Hormone and Metabolic Research

Volumn 43, Issue 11, 2011, Pages 766-773

  Adisakwattana, S ^a   Hsu, W H ^b   Yibchok Anun, S ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Ca 2+ influx; Diabetes; INS 1 cells; insulin secretion; p methoxycinnamic acid

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARGININE; CALCIUM CHANNEL BLOCKING AGENT; CINNAMIC ACID DERIVATIVE; GLIBENCLAMIDE; NIMODIPINE; POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; INSULIN RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CELL LINE; CINNAMATES; GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; KATP CHANNELS; KINETICS; MALE; MEMBRANE TRANSPORT MODULATORS; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; SECRETORY PATHWAY;

EID: 80054852513     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1287793     Document Type: Article

References (35)

1. Ashcroft F M. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest: 2005; 115 2047 2058 (Pubitemid 41134141)
2. Renstrm E, Barg S, Thvenod F, Rorsman P. Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensitive K+ channel-independent action. Diabetes: 2002; 51 01 S33 S36 (Pubitemid 34761491)
3. Rajan A S, Aguilar-Bryan L, Nelson D A, Yaney G C, Hsu W H, Kunze D L, Boyd A E. Ion channels and insulin secretion. Diabetes Care: 1990; 13 340 363 (Pubitemid 20092118)
4. Jackson J E, Bressler R. Clinical pharmacology of sulphonylurea hypoglycaemic agents. part 1 Drugs: 1981; 22 211 245 (Pubitemid 12218391)
5. Ferner R E. Neil HAW. Sulphonylureas and hypoglycaemia. Br Med J: 1988; 296 949 950
6. Gerich J E. Oral hypoglycemic agents. N Engl J Med: 1989; 321 1231 1245 (Pubitemid 19273033)
7. Jennings A, Wilson R, Ward J. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents. Diabetes Care: 1989; 12 203 208 (Pubitemid 19071489)
8. Perez-Alvarez V, Bobadilla R A, Muriel P. Structure-hepatoprotective activity relationship of 3,4-dihydroxycinnamic acid (caffeic acid) derivatives. J Appl Toxicol: 2001; 21 527 531 (Pubitemid 33130756)
9. Wiesner J, Mitsch A, Wissner P, Jomaa H, Schlitzer M. Structure-activity relationships of novel anti-malarial agents. Part 2: cinnamic acid derivatives. Bioorg Med Chem Lett: 2001; 11 423 424 (Pubitemid 32115862)
10. Natella F, Nardini M, Di Felice M, Scaccini C. Benzoic and cinnamic acid derivatives as antioxidants: structure-activity relation. J Agric Food Chem: 1999; 47 1453 1459 (Pubitemid 29217138)
11. Liu I M, Chi T C, Hsu F L, Chen C F, Cheng J T. Isoferulic acid as active principle from the rhizoma of Cimicifuga dahurica to lower plasma glucose in diabetic rats. Planta Med: 1999; 65 712 714
12. Nomura E, Kashiwada A, Hosoda A, Nakamura K, Morishita H, Tsuno T, Taniguchi H. Synthesis of amide compounds of ferulic acid, and their stimulatory effects on insulin secretion in vitro. Bioorg Med Chem: 2003; 11 3807 3813 (Pubitemid 36952279)
13. Adisakwattana S, Moonsan P, Yibchok-Anun S. Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J Agric Food Chem: 2008; 56 7838 7844
14. Adisakwattana S, Chantarasinlapin P, Thammarat H, Yibchok-Anun S. A series of cinnamic acid derivatives and their inhibitory activity on intestinal alpha-glucosidase. J Enzyme Inhib Med Chem: 2009; 24 1194 2000
15. Kim S R, Kang S Y, Lee K Y, Kim S H, Markelonis G J, Oh T H, Kim Y C. Anti-amnestic activity of E-p-methoxycinnamic acid from Scrophularia buergeriana. Brain Res Cogn Brain Res: 2003; 17 454 461 (Pubitemid 36869012)
16. Bylka W. E- and Z-p-methoxycinnamic acid from Aquilegia vulgaris. Acta Pol Pharm: 2004; 61 307 308 (Pubitemid 40188866)
17. 4-induced toxicity: action mechanism and structure-activity relationship. Planta Med: 2002; 68 407 411 (Pubitemid 34606682)
18. Kim S R, Sung S H, Jang Y P, Markelonis G J, Oh T H, Kim Y C. E-p-methoxycinnamic acid protects cultured neuronal cells against neurotoxicity induced by glutamate. Br J Pharmacol: 2002; 135 1281 1291 (Pubitemid 34262701)
19. Adisakwattana S, Sookkongwaree K, Roengsumran S, Petsom A, Ngamrojnavanich N, Chavasiri W, Deesamer S, Yibchok-anun S. Structure-activity relationships of trans-cinnamic acid derivatives on alpha-glucosidase inhibition. Bioorg Med Chem Lett: 2004; 14 2893 2896 (Pubitemid 38569758)
20. Yibchok-Anun S, Adisakwattana S, Moonsan P, Hsu W H. Insulin secretagogue activity of p-methoxycinnamic acid in rats, perfused rat pancreas and pancreatic -cell line. Basic Clin Pharmacol Toxicol: 2008; 102 476 482 (Pubitemid 351537789)
21. Adisakwattana S, Roengsamran S, Hsu W H, Yibchok-Anun S. Mechanisms of antihyperglycemic effect of p-methoxycinnamic acid in normal and streptozotocin-induced diabetic rats. Life Sci: 2005; 78 406 412 (Pubitemid 41597550)
22. 2+ channels in the beta cell. J Biol Chem: 1991; 266 837 843 (Pubitemid 21907192)
23. Cheng H, Grodnitzky J A, Yibchok-anun S, Ding J, Hsu W H. Somatostatin increases phospholipase D activity and phosphatidylinositol 4.5-bisphosphate synthesis in clonal -cells HIT-T15. Mol Pharmacol: 2005; 67 2162 2172 (Pubitemid 41007795)
24. Yibchok-Anun S, Jittaprasatsin W, Somtir D, Bunlunara W, Adisakwattana S. Insulin secreting and -glucosidase inhibitory activity of Coscinium fenestratum and postprandial hyperglycemia in normal and diabetic rats. J Med Plants Res: 2009; 3 646 651
25. + channel Kir6.1 expressed in human embryonic kidney cells. J Physiol: 1996; 494 709 714 (Pubitemid 26278848)
26. Park K H, Song S C, Akaike T. Determination of the specific interaction between sulfonylurea-incorporated polymer and rat islets. J Biochem (Tokyo): 2002; 131 359 364 (Pubitemid 34292826)
27. Pedersen S F, Owsianik G, Nilius B. TRP channels: an overview. Cell Calcium: 2005; 38 233 252 (Pubitemid 41283262)
28. Bandell M, Story G M, Hwang S W, Viswanath V, Eid S R, Petrus M J, Earley T J, Patapoutian A. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron: 2004; 41 849 857 (Pubitemid 38429729)
29. Liu Z, Jeppesen P B, Gregersen S, Chen X, Hermansen K. Dose- and glucose-dependent effects of amino acids on insulin secretion from isolated mouse islets and clonal INS-1E beta-cells. Rev Diabet Stud: 2008; 5 232 244
30. Thams P, Capito K. l -Arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide. Eur J Endocrinol: 1999; 140 87 93 (Pubitemid 29074773)
31. Piatti P M, Monti L D, Valsecchi G, Magni F, Setola E, Marchesi F, Galli-Kienle M, Pozza G, Alberti K G. Long-Term oral l -arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care: 2001; 24 875 880 (Pubitemid 33636062)
32. 3H]azidopine within the alpha 1 subunit. Proc Natl Acad Sci USA: 1991; 88 10769 10773 (Pubitemid 21915919)
33. Skasa M, Jungling E, Picht E, Schondube F, Luckhoff A. L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation. Basic Res Cardiol: 2001; 96 151 159 (Pubitemid 32236784)
34. 2+ concentration and insulin secretion in mouse beta-cells. Biochem J: 1996; 314 167 173
35. Hofmann F, Lacinova L, Klugbauer N. Voltage-dependent calcium channels: from structure to function. Rev Physiol Biochem Pharmacol: 1999; 139 33 87